These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 36420768)

  • 21. Preoperative Deprescribing for Medical Optimization of Older Adults Undergoing Surgery: A Systematic Review.
    Lee JW; Li M; Boyd CM; Green AR; Szanton SL
    J Am Med Dir Assoc; 2022 Apr; 23(4):528-536.e2. PubMed ID: 34861224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial-outcomes of the Opti-med study.
    Etherton-Beer C; Page A; Naganathan V; Potter K; Comans T; Hilmer SN; McLachlan AJ; Lindley RI; Mangin D
    Age Ageing; 2023 May; 52(5):. PubMed ID: 37247404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deprescribing in Older People Approaching End of Life: A Randomized Controlled Trial Using STOPPFrail Criteria.
    Curtin D; Jennings E; Daunt R; Curtin S; Randles M; Gallagher P; O'Mahony D
    J Am Geriatr Soc; 2020 Apr; 68(4):762-769. PubMed ID: 31868920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
    Anderson K; Freeman C; Foster M; Scott I
    J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing deprescribing tools for implementation in care homes: A qualitative study of the views of care home staff.
    Warmoth K; Rees J; Day J; Cockcroft E; Aylward A; Pollock L; Coxon G; Craig T; Walton B; Stein K
    Res Social Adm Pharm; 2024 Apr; 20(4):379-388. PubMed ID: 38245383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Person-Centred Care Including Deprescribing for Older People.
    Smith H; Miller K; Barnett N; Oboh L; Jones E; Darcy C; McKee H; Agnew J; Crawford P
    Pharmacy (Basel); 2019 Jul; 7(3):. PubMed ID: 31349584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia.
    Baysari MT; Duong M; Zheng WY; Nguyen A; Lo S; Ng B; Ritchie A; Le Couteur D; McLachlan A; Bennett A; Hilmer S
    BMJ Open; 2019 Sep; 9(9):e030950. PubMed ID: 31562155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis.
    Okafor CE; Keramat SA; Comans T; Page AT; Potter K; Hilmer SN; Lindley RI; Mangin D; Naganathan V; Etherton-Beer C
    J Am Med Dir Assoc; 2024 Mar; 25(3):539-544.e2. PubMed ID: 38307120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium.
    Carollo M; Boccardi V; Crisafulli S; Conti V; Gnerre P; Miozzo S; Omodeo Salè E; Pieraccini F; Zamboni M; Marengoni A; Onder G; Trifirò G;
    Aging Clin Exp Res; 2024 Mar; 36(1):63. PubMed ID: 38459218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'It's a job to be done'. Managing polypharmacy at home: A qualitative interview study exploring the experiences of older people living with frailty.
    Previdoli G; Alldred DP; Silcock J; Tyndale-Biscoe S; Okeowo D; Cheong VL; Fylan B
    Health Expect; 2024 Feb; 27(1):e13952. PubMed ID: 39102701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of deprescribing in older adults with dementia: a narrative review.
    Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacist-led telehealth deprescribing for people living with dementia and polypharmacy in primary care: A pilot study.
    Green AR; Quiles R; Daddato AE; Merrey J; Weffald L; Gleason K; Xue QL; Swarthout M; Feeser S; Boyd CM; Wolff JL; Blinka MD; Libby AM; Boxer RS
    J Am Geriatr Soc; 2024 Jul; 72(7):1973-1984. PubMed ID: 38488757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Polypharmacy with Increasing Drug Burden Index Exacerbates Frailty and Impairs Physical Function, with Effects Attenuated by Deprescribing, in Aged Mice.
    Mach J; Gemikonakli G; Logan C; Vander Wyk B; Allore H; Ekambareshwar S; Kane AE; Howlett SE; de Cabo R; Le Couteur DG; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1010-1018. PubMed ID: 32147704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploration of home care nurse's experiences in deprescribing of medications: a qualitative descriptive study.
    Sun W; Tahsin F; Barakat-Haddad C; Turner JP; Haughian CR; Abbass-Dick J
    BMJ Open; 2019 May; 9(5):e025606. PubMed ID: 31129579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study.
    Pickering AN; Hamm ME; Dawdani A; Hanlon JT; Thorpe CT; Gellad WF; Radomski TR
    J Am Geriatr Soc; 2020 Apr; 68(4):746-753. PubMed ID: 32067226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deprescribing in older people.
    Page AT; Potter K; Clifford R; Etherton-Beer C
    Maturitas; 2016 Sep; 91():115-34. PubMed ID: 27451330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferences for deprescribing antihypertensive medications amongst clinicians, carers and people living with dementia: a discrete choice experiment.
    Raghunandan R; Howard K; Ilomaki J; Hilmer SN; Gnjidic D; Bell JS
    Age Ageing; 2023 Aug; 52(8):. PubMed ID: 37596920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harm and Medication-Type Impact Agreement with Hypothetical Deprescribing Recommendations: a Vignette-Based Experiment with Older Adults Across Four Countries.
    Vordenberg SE; Weir KR; Jansen J; Todd A; Schoenborn N; Scherer AM
    J Gen Intern Med; 2023 May; 38(6):1439-1448. PubMed ID: 36376636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.